Cargando…

A cautionary note on the selectivity of oncolytic poxviruses

BACKGROUND: Oncolytic viruses selectively infect cancer cells while avoiding infection of normal cells. Usually, selectivity is demonstrated by injecting a virus into tumor-bearing mice and observing infection and lysis of tumor cells without infection of other tissues. The general view is that this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Bingtao, Guo, Zong Sheng, Bartlett, David L, Liu, Jia, McFadden, Grant, Shisler, Joanna L, Roy, Edward J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375109/ https://www.ncbi.nlm.nih.gov/pubmed/30805315 http://dx.doi.org/10.2147/OV.S189832

Ejemplares similares

Poxvirus tropism
por: McFadden, Grant
Publicado: (2005)

Role of cytokines in poxvirus host tropism and adaptation
por: Rahman, Masmudur M, et al.
Publicado: (2022)

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
por: Downs-Canner, Stephanie, et al.
Publicado: (2016)

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2015)

The Combination of Immunosuppression and Carrier Cells Significantly Enhances the Efficacy of Oncolytic Poxvirus in the Pre-Immunized Host
por: Guo, Z. Sheng, et al.
Publicado: (2010)

Oncolytic properties of non-vaccinia poxviruses
por: Ricordel, Marine, et al.
Publicado: (2018)

Oncolytic Poxvirus Armed with Fas Ligand Leads to Induction of Cellular Fas Receptor and Selective Viral Replication in FasR Negative Cancer
por: Sathaiah, Magesh, et al.
Publicado: (2011)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
por: Guo, Zong Sheng, et al.
Publicado: (2017)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Rahman, Masmudur M., et al.
Publicado: (2021)

Cowpox Virus: A New and Armed Oncolytic Poxvirus
por: Ricordel, Marine, et al.
Publicado: (2017)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus
por: Cho, Euna, et al.
Publicado: (2018)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
por: Everts, Anne, et al.
Publicado: (2020)

Oncolytic Viruses and the Immune System: The Dynamic Duo
por: Lemos de Matos, Ana, et al.
Publicado: (2020)

A Cautionary Note on “A Cautionary Note on the Use of Ornstein Uhlenbeck Models in Macroevolutionary Studies”
por: Grabowski, Mark, et al.
Publicado: (2023)

Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
por: Tosic, Vesna, et al.
Publicado: (2014)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Optimization of Codon Usage of Poxvirus Genes allows for Improved Transient Expression in Mammalian Cells
por: Barrett, John W., et al.
Publicado: (2006)

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma
por: Phelps, Michael P., et al.
Publicado: (2018)

Oscillators and Syllables: A Cautionary Note
por: Cummins, Fred
Publicado: (2012)

Oncolytic viruses as therapeutic cancer vaccines
por: Bartlett, David L, et al.
Publicado: (2013)

The Myxoma Poxvirus Protein, M11L, Prevents Apoptosis by Direct Interaction with the Mitochondrial Permeability Transition Pore
por: Everett, Helen, et al.
Publicado: (2002)

The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
por: Parato, Kelley A, et al.
Publicado: (2012)

Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus
por: Burgess, Hannah M., et al.
Publicado: (2018)

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
por: Guo, Zong Sheng, et al.
Publicado: (2014)

Membrane-Disrupting Molecules as Therapeutic Agents: A Cautionary Note
por: Regen, Steven L.
Publicado: (2020)

Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model
por: Lee, J-H, et al.
Publicado: (2009)

Important Questions Deserve Rigorous Analysis: A Cautionary Note About Selection Bias
por: Petito, Lucia C., et al.
Publicado: (2021)

Microglial cells in astroglial cultures: a cautionary note
por: Saura, Josep
Publicado: (2007)

Mycoplasmas and Human prostate cancer: An exciting but cautionary note
por: Lo, Shyh-Ching, et al.
Publicado: (2011)

Blocking endogenous peroxidases: a cautionary note for immunohistochemistry
por: Radulescu, Razvan Tudor, et al.
Publicado: (2007)

A cautionary note on testing latent variable models
por: Ropovik, Ivan
Publicado: (2015)

Noisy Preferences in Risky Choice: A Cautionary Note
por: Bhatia, Sudeep, et al.
Publicado: (2017)

A Cautionary Note on the Use of Genotype Callers in Phylogenomics
por: Duchen, Pablo, et al.
Publicado: (2020)

NHS reference costs: a history and cautionary note
por: Amies-Cull, Ben, et al.
Publicado: (2023)

Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses
por: Sampath, Padma, et al.
Publicado: (2013)

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
por: Ricordel, Marine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_565v8pkfpfbdlsvr3dusp58fb7